Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Spinal Division Shows Signs Of Turnaround Under New Chief

This article was originally published in The Gray Sheet

Executive Summary

Medtronic says its spinal business has begun moving in the right direction under the leadership of Steve LaNeve, who became president of the unit in May
Advertisement

Related Content

Medtronic To Launch Bryan Cervical Disc In July
Medtronic To Launch Bryan Cervical Disc In July
Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling
Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling
Expectations For Artificial Disc Trials Challenge Market Hopefuls
Xience V / Promus Drug-Eluting Stent Is Off And Running On U.S. Market
Medtronic R&D Spending Shifts To Neuromodulation, Diabetes
Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
Advertisement
UsernamePublicRestriction

Register

MT026493

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel